Software/Technology

Explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development. Gain insights to reduce attrition rates and optimise development programmes through eff ective assay development. Learn about the latest multiplexed tools impacting biomarker research and validation, from multi-omic cytometry through to mass spectrometry & immunoassays.

This one day event, the day before DPHARM, is centered on connecting the value chain of patient data
(from early drug research to commercialization) with digital technology.

This conference formerly called “Mobile in Clinical Trials” focused on assessing, employing and scaling
mobile tech to help more patients participate and be able to collect patient data remotely.

The conference is expanding to assess all sources of patient data including patient experience data, and how
to best connect the data to optimize clinical trials for all stakeholders.

This conference will include a variety of technological solutions and consider how patient data could be
better utilized in clinical trials.

A gathering of 220+ of the leading innovators, investors and executives from around the nation discussing the timeliest issues and opportunities. 

In a market that is constantly adapting and adjusting to the needs of the healthcare field, real-world evidence (RWE) is increasingly becoming important for regulatory and reimbursement decision-making. RWE, in relation to the real-world data that is collected in combination with the advancement of artificial intelligence-based analytics platforms, has led to the realtime analysis of data to better understand and gain insights on disease, approaches to treatment, and how to substantiate coverage decisions.

The 2023 Annual Meeting & Expo reflects our focus on cutting-edge research and innovation across our strong discipline that will keep you up-to-date with new science and inspire new ideas. Most importantly, this event will offer you the ability to network, form friendships among your peers and foster new collaborations within the delivery science and technology field. We have a full and exciting program over the conference duration with highly prominent plenary talks, technical sessions covering a wide scope of topics, industry led workshops and technical forums.

Our established genomics event will be returning to London this autumn featuring the 15th Annual Next Generation Sequencing & Clinical Diagnostics, 10th Annual Single Cell Analysis, 8th Annual Genome Editing and 4th Annual Digital PCR Congresses. From clinical genomics updates and single cell analysis current & emerging tools, through to genome editing techniques for assessing specificity for on and off targets and applications of digital PCR in oncology, this is the event to attend this fall to stay at the forefront of genomics research.

Featuring focused discussions, presentations, and networking on multi-omic data integration, single cell & spatial analysis, genome editing in drug discovery & development and novel genome editing technologies.

An intensive 2-day in person meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development. From new and exciting to the latest in products & services, this event will bring together over 150 leading companies for in-depth discussions, knowledge sharing and focused networking. Colocated with the RNA Therapeutics & Delivery Europe: In Person.

The Clinical Trial Supply West Coast will offer a fresh insight into the latest regulatory updates, global clinical supply chains, advanced technologies such as remote and hybrid trials, Artificial Intelligence, and more. With presentations, roundtables, and panel discussions on all the hottest industry trends and supply chain challenges, the 2-day event promises to provide the industry an unmissable opportunity to learn and network to help them succeed post-Covid.

An intensive 2-day in person meeting that delves into the latest in oligonucleotides chemistry, process & analytical development, therapeutics, antisense therapy & a meeting place for experts working within cutting-edge oligo research & therapeutic development. From new and exciting to the latest in products & services, this event will bring together over 150 leading companies for in-depth discussions, knowledge sharing and focused networking. Colocated with the RNA Therapeutics & Delivery Europe: In Person.